In vitro immunization of human lymphocytes. I. Production of human monoclonal antibodies against bombesin and tetanus toxoid.

M K Ho, N Rand, J. Murray, +2

The Journal of Immunology

Tetanus ToxoidVitro ImmunizationAllergyImmunologyImmunophenotyping +12

Isolation and partial characterization of an antigen-specific T-cell factor associated with the suppression of delayed type hypersensitivity.

Robert W. Rosenstein, J. Murray, Robert E. Cone, +3

Proceedings of the National Academy of Sciences

Adaptive Immune SystemCellular ImmunologyImmunologyAntigen ProcessingCd4 T Cell Responses +19

EMACO in High Risk Gestational Trophoblast Disease ‐ The Australian Experience

Michael Quinn, J. Murray, Martin Friedlander, +5

Australian and New Zealand Journal of Obstetrics and Gynaecology

Affinity-purified antigen-specific products produced by T cells share epitopes recognized by heterologous antisera raised against several different antigen-specific products from T cells

Robert E. Cone, Robert W. Rosenstein, Charles A. Janeway, +12

Cellular Immunology

Affinity-purified Antigen-specific ProductsT Cells ShareAutoimmune DiseaseAllergyAdaptive Immune System +11

Purification and characterization of TNP-specific immunoregulatory molecules produced by T cells sensitized by picrylchloride (PC1F).

W Ptak, R K Gershon, Robert W. Rosenstein, +2

The Journal of Immunology

T-regulatory CellImmunologyImmune RegulationImmunologic MechanismAntigen Processing +16

Tumor activity confirmation and isodose curve display for patients receiving iodine-131-labeled 16.88 human monoclonal antibody

Alev K. Erdi, B. W. Wessels, Robert L. DeJager, +14

Cancer

Tumor Activity ConfirmationOncologic ImagingPathologyPositron Emission TomographyNeuro-oncology +19

A phase I/II and pharmacologic study of MM-111 in patients with advanced, refractory HER2-positive (HER2+) cancers.

C.S. Denlinger, M. Beeram, A. W. Tolcher, +6

Journal of Clinical Oncology

Breast OncologyCancer ManagementImmunologyPathologyImmunotherapeutics +20

Delayed-type hypersensitivity reactions to tumor-associated antigens in colon carcinoma patients immunized with an autologous tumor cell/Bacillus Calmette-Guérin vaccine.

Elisabeth Bloemena, H.E. Gall, Janet H. Ransom, +7

PubMed

ImmunologyTumor-associated AntigensAntigen ProcessingCd4 T Cell ResponsesImmunotherapeutics +17

Characterization of T-cell surface proteins bound by heterologous antisera to antigen-specific T-cell products.

Robert E. Cone, Robert W. Rosenstein, J. Murray, +3

Proceedings of the National Academy of Sciences

Laboratory ImmunologyImmunologyAntigen-specific T-cell ProductsImmunodominanceImmunologic Mechanism +16

A phase I/II study of MM-111, a novel bispecific antibody that targets the ErB2/ErB3 heterodimer, in combination with trastuzumab in advanced refractory HER2-positive breast cancer.

M. J. Higgins, N. Gabrail, K. Miller, +9

Journal of Clinical Oncology

Breast OncologyPhase I/ii StudyImmunologyCancer BiologyTumor Biology +14